Gene Therapy Market Report

Gene Therapy Market Insights

Gene Therapy Market is likely to witness an impressive CAGR of 27.8% during the forecast period. The prime factors contributing to the growth of the market are rising incidences of cancer, and other chronic diseases, availability of reimbursements, and increasing approvals and launches of new products.

Market Share Analysis

Wish to Get a Free Sample? Register Here

Gene Therapy Market Share: By Indication Type

Based on the indication type, the gene therapy market is segmented as neurological diseases, cancer, duchenne muscular dystrophy, heptological, and others. The cancer segment is expected to experience the highest growth in the market during the forecast period. This growth can be attributed to the approval of a growing number of gene therapies for the treatment of cancer and the rising incidences of hematologic cancers.

Gene Therapy Market Share: By Vector Type

Based on the vector type, the market is segmented as non-viral and viral vectors. The non-viral vectors’ segment has been further bifurcated into oligonucleotides and others; and the viral vectors’ segment has been further bifurcated into retroviral vectors, adeno-associated virus vectors, and others. The non-viral vectors’ segment is expected to grow at a higher rate over the forecast period, owing to the higher market penetration of oligonucleotide-based non-viral vector gene therapies.

Gene Therapy Market Share: By Region

In terms of regions, North America is estimated to be the largest market during the forecast period with lucrative growth opportunities. This growth can be attributed to the presence of major players, rising prevalence of chronic diseases, high and increasing healthcare expenditure, presence of advanced healthcare infrastructure, and availability of reimbursements. Europe and Asia-Pacific are also expected to offer substantial growth opportunities during the forecast period.

Know which region offers best growth opportunities. Register Here

Some of the major players in the gene therapy market are Biogen, Inc., Novartis International AG, Gilead Sciences, Inc., Spark Therapeutics, Inc., MolMed S.p.A., Orchard Therapeutics plc., Sibiono GeneTech Co. Ltd., Shanghai Sunway Biotech Co., Ltd., Bluebird Bio, Human Stem Cells Institute PJSC, AnGes MG, Inc., Alnylam Pharmaceuticals, Inc., Sarepta Therapeutics, Inc., Jazz Pharmaceuticals, Inc., Akcea Therapeutics, and Dynavax Technologies Corporation.

Market Scope & Segmentation

Gene therapy is a technique which uses the introduction of DNA into a patient’s body in order to treat or prevent a disease. A functioning gene is present in the introduced DNA, to correct the effects of a disease, which causes mutations. This therapy aims at reestablishing normal function and involves repairing, repressing, or replacing dysfunctional genes that cause disease. Gene therapy:

• Serves as a promising treatment option for some genetic diseases such as muscular dystrophy and cystic fibrosis, certain inherited disorders, cancer, and viral infections.
• Addresses the root cause of severe diseases by aiding in drug development to identify the right target and approach.
• Provides a path to produce the functional protein in case of certain disorders where known genetic mutations lead to deficient or nonfunctional protein production by fixing the underlying defect.
• Poses a relatively low risk as a new gene introduced will integrate itself into the genome of the patient and continue functioning without hampering the operations of other genes.

This report studies the market covering a period of 12 years of trend and forecast. The report provides detailed insights into the market dynamics to enable informed business decision making and growth strategy formulation based on the opportunities present in the market.

The gene therapy market is segmented into the following categories. 

Gene Therapy Market Size, Share, & Forecast, by Vector Type:

• Non-Viral Vectors
  • (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
  • (Vector Type Analysis: Oligonucleotides and Other Non-Viral Vectors)
• Viral Vectors
  • (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
  • (Vector Type Analysis: Retroviral Vectors, Adeno-Associated Virus Vectors, and Other Viral Vectors)

Gene Therapy Market Size, Share, & Forecast, by Indication Type:

• Neurological Diseases (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
• Cancer (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
• Duchenne Muscular Dystrophy (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
• Hepatological Diseases (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
• Others (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)

Gene Therapy Market Size, Share, & Forecast, by Delivery Method Type:

• In Vivo Gene Therapy (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
• Ex Vivo Gene Therapy (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)

Gene Therapy Market Size, Share, & Forecast, by Region:

• North America (Country Analysis: the USA, Canada, and Mexico) 
• Europe (Country Analysis: Germany, France, the UK, Russia, Spain, and Rest of Europe)
• Asia-Pacific (Country Analysis: China, Japan, India, South Korea, and Rest of Asia-Pacific)
• Rest of the World (Sub-Region Analysis: Latin America, the Middle East, and Others)

Want to know the most attractive market segments? Register Here

Research Methodology

This report offers high-quality insights and is the outcome of detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact book, press release, journals, investor presentation, white papers, patents, and articles have been leveraged to gather the data. We conducted more than 10 detailed primary interviews with the market players across the value chain in all four regions and with industry experts to obtain both the qualitative and quantitative insights.

Report Features

This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision making for the existing market players as well as those willing to enter the market. The following are the key features of the report:

• Market structure: Overview, industry life cycle analysis, supply chain analysis
• Market environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis
• Market trend and forecast analysis
• Market segment trend and forecast
• Competitive landscape and dynamics: Market share, product portfolio, product launches, etc.
• Attractive market segments and associated growth opportunities
• Emerging trends
• Strategic growth opportunities for the existing and new players
• Key success factors

Report Customization Options

With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

Company Profiling

• Detailed profiling of additional market players (up to 3 players)
• SWOT analysis of key players (up to 3 players)

Market Segmentation

• Current market segmentation of any one of the vector types, by indication type.  

Competitive Benchmarking

• Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances

Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at [email protected].